Related references
Note: Only part of the references are listed.Scaffold and Parasite Hopping: Discovery of New Protozoal Proliferation Inhibitors
Baljinder Singh et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria
Maria Alvarez-Bardon et al.
MARINE DRUGS (2020)
Walking a tightrope: drug discovery in visceral leishmaniasis
Rafael Balana-Fouce et al.
DRUG DISCOVERY TODAY (2019)
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
Susan Wyllie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis
Michael G. Thomas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art
Rebecca L. Charlton et al.
PARASITOLOGY (2018)
Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity
Jean Dam et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Nicholas J. Kassebaum et al.
LANCET (2016)
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
Shilpi Khare et al.
NATURE (2016)
Hit and lead criteria in drug discovery for infectious diseases of the developing world
Kei Katsuno et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Michael J. Waring et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Antileishmanial drug discovery: comprehensive review of the last 10 years
Jaiprakash N. Sangshetti et al.
RSC ADVANCES (2015)
Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
Advait S. Nagle et al.
CHEMICAL REVIEWS (2014)
Structure-Based Design of Potent and Selective Leishmania N-Myristoyltransferase Inhibitors
Jennie A. Hutton et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Clinical development success rates for investigational drugs
Michael Hay et al.
NATURE BIOTECHNOLOGY (2014)
Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case
Thierry Kogej et al.
DRUG DISCOVERY TODAY (2013)
Therapeutic Options for Visceral Leishmaniasis
Begona Monge-Maillo et al.
DRUGS (2013)
Drug Discovery for Neglected Diseases: Molecular Target-Based and Phenotypic Approaches
Ian H. Gilbert
JOURNAL OF MEDICINAL CHEMISTRY (2013)
A High-Throughput Screen To Identify Inhibitors of ATP Homeostasis in Non-replicating Mycobacterium tuberculosis
Puiying A. Mak et al.
ACS CHEMICAL BIOLOGY (2012)
Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents
Sophie Marhadour et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Principles of early drug discovery
J. P. Hughes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Identification of Inhibitors that Block Vaccinia Virus Infection by Targeting the DNA Synthesis Processivity Factor D4
Manunya Nuth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Drug Resistance in Visceral Leishmaniasis
Helena C. Maltezou
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Extended-Connectivity Fingerprints
David Rogers et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?
Francois Chappuis et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Comparison of shape-matching and docking as virtual screening tools
Paul C. D. Hawkins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Share Paper
